Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer.

Duan Z, Miller HD, Fu X, Ge D, Jin B, Moustafa AA, Lan R, Zhang K, Chen Z, You Z.

Am J Clin Exp Urol. 2019 Aug 25;7(4):249-261. eCollection 2019.

2.

Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer.

Cunningham D, Zhang Q, Liu S, Parajuli KR, Nie Q, Ma L, Zhang A, Chen Z, You Z.

Am J Clin Exp Urol. 2018 Jun 15;6(3):114-122. eCollection 2018.

3.

IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms.

Tse BW, Russell PJ, Lochner M, Förster I, Power CA.

PLoS One. 2011;6(9):e24241. doi: 10.1371/journal.pone.0024241. Epub 2011 Sep 15.

4.

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

Saika T, Kusaka N, Mouraviev V, Satoh T, Kumon H, Timme TL, Thompson TC.

Cancer Gene Ther. 2006 Jan 1;13(1):91-8.

PMID:
16052232
5.

Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model.

Zhang Q, Liu S, Ge D, Cunningham DM, Huang F, Ma L, Burris TP, You Z.

Prostate. 2017 Jun;77(8):888-899. doi: 10.1002/pros.23343. Epub 2017 Feb 27.

6.

Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.

Galvan DL, O'Neil RT, Foster AE, Huye L, Bear A, Rooney CM, Wilson MH.

PLoS One. 2015 Oct 16;10(10):e0140744. doi: 10.1371/journal.pone.0140744. eCollection 2015.

7.

Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.

Lim SM, Kang GD, Jeong JJ, Choi HS, Kim DH.

Phytomedicine. 2016 Feb 15;23(2):131-40. doi: 10.1016/j.phymed.2016.01.002. Epub 2016 Jan 22.

PMID:
26926174
8.

The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma.

Wainwright DA, Sengupta S, Han Y, Ulasov IV, Lesniak MS.

PLoS One. 2010 Oct 23;5(10):e15390. doi: 10.1371/journal.pone.0015390.

9.

Increased Th17 differentiation in aged mice is significantly associated with high IL-1β level and low IL-2 expression.

Lim MA, Lee J, Park JS, Jhun JY, Moon YM, Cho ML, Kim HY.

Exp Gerontol. 2014 Jan;49:55-62. doi: 10.1016/j.exger.2013.10.006. Epub 2013 Oct 17.

10.

Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.

Brunsing RL, Prossnitz ER.

Immunology. 2011 Sep;134(1):93-106. doi: 10.1111/j.1365-2567.2011.03471.x. Epub 2011 Jul 2.

11.

A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.

Cantini G, Pisati F, Mastropietro A, Frattini V, Iwakura Y, Finocchiaro G, Pellegatta S.

Cancer Immunol Immunother. 2011 Dec;60(12):1739-50. doi: 10.1007/s00262-011-1069-4. Epub 2011 Jul 21.

PMID:
21779877
12.

Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.

Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright GL Jr, Schellhammer PF, Qian J, Ciavarra RP.

Int J Cancer. 2003 Dec 10;107(5):773-80.

13.

Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.

Yang H, Zhang Y, Wu M, Li J, Zhou W, Li G, Li X, Xiao B, Christadoss P.

Inflamm Res. 2010 Mar;59(3):197-205. doi: 10.1007/s00011-009-0087-6. Epub 2009 Sep 19.

PMID:
19768385
14.

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

Zhou W, Zhou X, Gaowa S, Meng Q, Zhan Z, Liu J, Li J, Fan H, Liu Z.

Transplantation. 2015 Jul;99(7):1356-64. doi: 10.1097/TP.0000000000000526.

PMID:
25856405
15.

[Th17 in the immunity against parasitic infection].

Liu F, Yin HB, Su C.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Oct 30;26(5):382-6. Review. Chinese.

PMID:
19157306
16.

B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.

Lee IF, Wang X, Hao J, Akhoundsadegh N, Chen L, Liu L, Langermann S, Ou D, Warnock GL.

Cell Immunol. 2013 Mar;282(1):1-8. doi: 10.1016/j.cellimm.2013.03.005. Epub 2013 Apr 4.

PMID:
23623902
17.

[The role of Th17 cells in anti-cancer immunity].

Hus I, Maciag E, Roliński J.

Postepy Hig Med Dosw (Online). 2010 May 25;64:244-50. Review. Polish.

18.

Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.

Nasu Y, Bangma CH, Hull GW, Yang G, Wang J, Shimura S, McCurdy MA, Ebara S, Lee HM, Timme TL, Thompson TC.

Prostate Cancer Prostatic Dis. 2001;4(1):44-55.

19.

A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.

Rahim S, Minas T, Hong SH, Justvig S, Çelik H, Kont YS, Han J, Kallarakal AT, Kong Y, Rudek MA, Brown ML, Kallakury B, Toretsky JA, Üren A.

PLoS One. 2014 Dec 5;9(12):e114260. doi: 10.1371/journal.pone.0114260. eCollection 2014.

20.

A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.

Chen H, Wang W, Xie H, Xu X, Wu J, Jiang Z, Zhang M, Zhou L, Zheng S.

Transpl Immunol. 2009 Jul;21(3):155-61. doi: 10.1016/j.trim.2009.03.006. Epub 2009 Apr 7.

PMID:
19358887

Supplemental Content

Support Center